World-Leaders In Psychiatric Research

High Impact Research

Landmark publications from the RISE Institute team in the world's leading psychiatric and medical journals.

The Lancet 2020 · Vol 396

Bipolar Disorders

McIntyre RS, Berk M, Brietzke E, Goldstein BI, López-Jaramillo C, Kessing LV, Malhi GS, Nierenberg AA, Rosenblat JD, Majeed A, Vieta E, Vinberg M, Young AH, Mansur RB

IF ~169 Cited: 1,500+ doi:10.1016/S0140-6736(20)31544-0
World Psychiatry 2023 · Vol 22, No. 3

Treatment-Resistant Depression: Definition, Prevalence, Detection, Management, and Investigational Interventions

McIntyre RS, Alsuwaidan M, Baune BT, Berk M, Demyttenaere K, Goldberg JF, Gorwood P, Ho R, Kasper S, Kennedy SH, Ly-Uson J, Mansur RB, McAllister-Williams RH, Murrough JW, Nemeroff CB, Nierenberg AA, Rosenblat JD, Sanacora G, Schatzberg AF, Shelton R, Stahl SM, Trivedi MH, Vieta E, Vinberg M, Williams N, Young AH, Maj M

IF ~73 Cited: 300+ doi:10.1002/wps.21120
World Psychiatry 2022 · Vol 21, No. 3

The Clinical Characterization of the Adult Patient with Bipolar Disorder Aimed at Personalization of Management

McIntyre RS, Alda M, Baldessarini RJ, Bauer M, Berk M, Correll CU, Fagiolini A, Fountoulakis K, Frye MA, Grunze H, Kessing LV, Miklowitz DJ, Parker G, Post RM, Swann AC, Suppes T, Vieta E, Young A, Maj M

IF ~73 Cited: 200+ doi:10.1002/wps.20997
JAMA Psychiatry 2019 · Vol 76, No. 8

Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression: A Randomized Clinical Trial

McIntyre RS, Subramaniapillai M, Lee Y, Pan Z, Carmona NE, Shekotikhina M, Rosenblat JD, Brietzke E, Soczynska JK, Cosgrove VE, Miller S, Fischer EG, Kramer NE, Dunlap K, Suppes T, Mansur RB

IF ~22 Cited: 200+ doi:10.1001/jamapsychiatry.2019.0779
Med · Cell Press 2026 · Vol 7, No. 1

Semaglutide for the Treatment of Cognitive Dysfunction in Major Depressive Disorder: A Randomized Clinical Trial

Badulescu S, Gill H, Shah H, Brudner R, Phan L, Di Vincenzo JD, Tabassum A, Armanyous M, Llach CD, Rosenblat JD, McIntyre RS, Mansur RB

Novel RCT GLP-1 agonist & cognition doi:10.1016/j.medj.2025.100916

RISE Institute · Research

Recent Publications

The following publications represent the latest peer-reviewed research from our consulting team. This feed is updated automatically to reflect new work across psychiatry, psychopharmacology, and mood disorder research.

RM

Dr. Roger S. McIntyre

MD, FRCPC · University of Toronto

HG

Dr. Hartej Gill

PhD · University of Toronto

MS

Dr. Margarita Shekotikhina

MD, FRCPC · Trillium Health Partners

Latest Articles

Auto-updating via PubMed
Source PubMed / NCBI National Library of Medicine

Publications listed are sourced automatically from PubMed and reflect the individual research activities of the named authors. Inclusion does not imply endorsement by or affiliation with RISE Institute Inc. for all listed works. For full text access, please follow the links provided by the PubMed feed or contact the respective authors directly.

RISE Institute · Careers

Join Our Research Team

We are always interested in connecting with talented individuals who are passionate about advancing psychiatric science. If you are driven by meaningful research and want to contribute to work that directly impacts patient care, we would like to hear from you.

01
Clinical Research Coordinators
Individuals with experience in clinical trial coordination, participant management, and Good Clinical Practice (GCP) standards. Prior CRO or hospital-based research experience is an asset.
02
Psychiatric Researchers & Scientists
Researchers with a background in psychiatry, neuroscience, or psychopharmacology. We welcome those at the postdoctoral, graduate, or early faculty level with a focus on mood disorders.
03
Regulatory & Data Professionals
Specialists in regulatory affairs, biostatistics, or clinical data management with experience supporting Phase 2–4 trials and familiarity with Health Canada or FDA submission requirements.
04
Medical Writers & Communicators
Professionals with experience producing peer-reviewed manuscripts, clinical study reports, regulatory documents, or scientific communications in psychiatry or related fields.

What We Offer

World-Class Mentorship

Work alongside internationally recognized leaders in psychiatric research and psychopharmacology.

Meaningful Research

Contribute to Phase 3 clinical trials and research programs with direct impact on the treatment of mood disorders.

Publication Opportunities

Collaborate on peer-reviewed publications and scientific communications in leading psychiatric journals.

Ready to Apply?

Submit Your Interest

Send us your background and area of interest. We review all submissions and will reach out when a suitable opportunity arises.

Get in Touch